@prefix this: . @prefix sub: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-gda: . @prefix dgn-void: . sub:head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:publicationInfo; a np:Nanopublication . } sub:assertion { dgn-gda:DGN6f3f6d748862bebde79e322aed4f9eb7 sio:SIO_000628 miriam-gene:338, lld:C0033860; a sio:SIO_001122 . } sub:provenance { sub:assertion dcterms:description "[The patients with psoriasis with the PON1 M (M/L + M/M) allele had higher MDA levels (4�12 � 0�88 vs. 2�24 � 0�55 ?mol L(-1) , P < 0�001), apolipoprotein B (APOB)/APOA1 ratio (0�91 � 0�66 vs. 0�66 � 0�35, P = 0�004), APOB (111 � 38�7 vs. 88�3 � 22�5 mg mL(-1) , P = 0�001) and lipoprotein(a) [LP(a)] (21�9 � 18�4 vs. 15�8 � 16�6 mg mL(-1) , P = 0�034), but lower ARE activity (39�6 � 11 vs. 45�9 � 11�8 U mL(-1) , P = 0�031) than the control subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:22835076; prov:wasDerivedFrom dgn-void:BEFREE; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:BEFREE pav:importedOn "2017-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } sub:publicationInfo { this: dcterms:created "2017-10-17T13:10:32+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v5.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v5.0.0" . }